Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Pluri Inc (PLUR)

Pluri Inc (PLUR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pluri Inc MATAM ADVANCED TECHNOLOGY PARK BUILDING NO. 5 HAIFA L3 3508409 ISR

https://pluri-biotech.com P: 972-74-710-8600 F: 972-747-1087

Description:

Pluri Inc. is a biotechnology company. Its technology platform, a patented and validated state-of-the-art 3D cell expansion system, advances novel cell-based solutions for a range of medicine and climate change to food scarcity, animal cruelty and beyond. Pluri Inc., formerly known as Pluristem Therapeutics Inc., is based in HAIFA, Israel.

Key Statistics

Overview:

Market Capitalization, $K 25,406
Enterprise Value, $K 43,306
Shares Outstanding, K 5,185
Annual Sales, $ 290 K
Annual Net Income, $ -28,320 K
Last Quarter Sales, $ 110 K
Last Quarter Net Income, $ -4,910 K
EBIT, $ -24,230 K
EBITDA, $ -23,870 K
60-Month Beta 1.45
% of Insider Shareholders 24.30%
% of Institutional Shareholders 16.59%
Float, K 3,925
% Float 75.70%
Short Volume Ratio 0.55

Growth:

1-Year Return -33.21%
3-Year Return -85.55%
5-Year Return -90.51%
5-Year Revenue Growth 480.00%
5-Year Earnings Growth 68.80%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.96 on 02/12/24
Latest Earnings Date 05/14/24
Earnings Per Share ttm -4.64
EPS Growth vs. Prev Qtr 0.00%
EPS Growth vs. Prev Year 50.00%
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-8 on 04/01/24

PLUR Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -177.94%
Return-on-Assets % -49.60%
Profit Margin % -9,765.52%
Debt/Equity 3.69
Price/Sales 91.96
Price/Cash Flow N/A
Price/Book 3.92
Book Value/Share 1.28
Interest Coverage -33.39
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar